DALLAS, December 2, 2014 /PRNewswire/ --
ReportsnReports.com adds Global Herpes Market 2014-2018 research report (available starting Dec 3, 2014) of 67 pages to the pharmaceuticals and healthcare industry intelligence collection of its online library.
Promising new therapies will inflate the global herpes market for the next 4 years according to this report that indicates room for growth due to unmet treatment requirements. The approved antivirals in the market only reduce the frequency of herpes simplex, but do not cure the disease completely. This is providing ample opportunities for investors in the Global Herpes Market. Complete report on worldwide herpes market for 2014-2018 is available starting Dec 3 2014 at http://www.reportsnreports.com/reports/319492-global-herpes-market-2014-2018.html .
This herpes industry research highlights novel therapies, concentrating on increased safety in combination with increasing patient awareness and compliance. Many promising therapies, especially for Cytomegalovirus (CMV) infections are expected to be launched during the forecast period. There are few first-in-class drugs that are undergoing development for the treatment and prevention of herpes viral infections. The launch of vaccines like GSK1437173A and V212 and pipeline candidates like TransVax are expected to propel this market in the coming years.
The herpes market currently consists of four primary branded drugs and numerous generic drugs. However, competition in the market is expected to intensify with the presence of numerous small vendors, who are adopting extensive marketing and licensing strategies to gain market share. This report covers the present scenario and the growth prospects of the Global Herpes market for the period 2013-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs and vaccines used in the treatment and prevention of herpes simplex, herpes zoster and CMV infections that are available in the market.
Companies active in the herpes market and discussed in this research include Gilead Sciences, GSK, Merck, Novartis, Agenus, AiCuris, aRigen Pharmaceuticals, Astellas Pharma, CytoGenix, Epiphany Biosciences, F. Hoffmann-La Roche, Genocea Biosciences and NanoBio. Order a copy of this report at http://www.reportsnreports.com/Purchase.aspx?name=319492 . The report presents the vendor landscape and a corresponding detailed analysis of the vendors in the Global Herpes market. In addition, the report discusses the major drivers that influence the growth of the market and outlines the challenges faced by the vendors and the market.
The 2014 Strategies for the Herpes Markers Diagnostic Testing Market research report presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Herpes definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for Herpes Simplex I/II and Herpes Type VI testing for Hospitals, Commercial / Private Labs, Physician Offices and Public Health Labs. For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
The Herpes Markers Testing Market 2014: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape report presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Herpes definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for Herpes Simplex I/II and Herpes Type VI testing. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers is also provided in this research.
Competitive assessment of Abbott, Affymetrix, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, Diamedix, DiaSorin, Eiken Chemical, Enzo Biochem, Fujirebio, Gen-Probe,
Hologic, ID Biomedical, Innogenetics/Solvay, Kreatech, Life Technology, Lonza, Nanogen/Elitech, Novartis Diagnostics Ortho-Clinical Diagnostics Qiagen, Roche, Scienion, Sequenom, SeraCare, Siemens, Takara Bio, Thermo Fisher, Wallac and Wako is provided in this report available at http://www.reportsnreports.com/reports/273976-herpes-markers-testing-market-2014-us-europe-france-germany-italy-spain-uk-japan-emerging-opportunities-supplier-shares-country-forecasts-innovative-technologies-competitive-landscape.html .
Explore more pharmaceutical market reports as well as other newly published research on the healthcare industry at http://www.reportsnreports.com/market-research/healthcare/ .
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Connect With Us on:
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts